Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for the Prophylaxis and Treatment of Peritoneal Metastases From Colorectal Cancer: A GRADE-Approach for Evidence Evaluation and Recommendations.
Goéré D, Kusamura S, Lurvink RJ, Cinquini M, Piso P, Levine E, Hubner M, Cortés Guiral D, Brandl A, Spinelli A, De Hingh IHJT, Deraco M. Goéré D, et al. Among authors: lurvink rj. J Surg Oncol. 2024 Oct 25. doi: 10.1002/jso.27957. Online ahead of print. J Surg Oncol. 2024. PMID: 39450445 Review.
Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II).
van de Vlasakker VCJ, Rauwerdink P, Rovers KPB, Wassenaar EC, Creemers GJ, Los M, Burger JWA, Nienhuijs SW, Kranenburg O, Wiezer MJ, Lurvink RJ, Boerma D, de Hingh IHJT. van de Vlasakker VCJ, et al. Among authors: lurvink rj. Surg Endosc. 2024 Nov;38(11):6566-6576. doi: 10.1007/s00464-024-11185-z. Epub 2024 Sep 16. Surg Endosc. 2024. PMID: 39285036 Free PMC article. Clinical Trial.
First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).
Rauwerdink P, van de Vlasakker VCJ, Wassenaar ECE, Rovers KP, Los M, Herbschleb KH, Creemers GM, Thijs AMJ, Raicu MG, Huysentruyt CJR, van der Hoeven EJRJ, Nederend J, Peeters RYM, Deenen MJ, Elias SG, Fijneman RJA, Constantinides A, Kranenburg O, Burger PWA, Nienhuijs SW, Wiezer RJ, Lurvink RJ, de Hingh IHJT, Boerma D. Rauwerdink P, et al. Among authors: lurvink rj. Eur J Surg Oncol. 2024 Sep;50(9):108487. doi: 10.1016/j.ejso.2024.108487. Epub 2024 Jun 13. Eur J Surg Oncol. 2024. PMID: 38905732 Clinical Trial.
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
van de Vlasakker VCJ, Guchelaar NAD, van den Heuvel TBM, Lurvink RJ, van Meerten E, Bax RJF, Creemers GM, van Hellemond IEG, Brandt-Kerkhof ARM, Madsen EVE, Nederend J, Koolen SLW, Nienhuijs SW, Kranenburg O, de Hingh IHJT, Verhoef C, Mathijssen RHJ, Burger JWA; Dutch Peritoneal Oncology Group; Dutch Colorectal Cancer Group. van de Vlasakker VCJ, et al. Among authors: lurvink rj. BMJ Open. 2024 Jan 18;14(1):e077667. doi: 10.1136/bmjopen-2023-077667. BMJ Open. 2024. PMID: 38238055 Free PMC article.
Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery.
van de Vlasakker VCJ, Lurvink RJ, Wassenaar EC, Rauwerdink P, Bakkers C, Rovers KP, Bonhof CS, Burger JWA, Wiezer MJ, Boerma D, Nienhuijs SW, Mols F, de Hingh IHJT. van de Vlasakker VCJ, et al. Among authors: lurvink rj. Sci Rep. 2023 Nov 22;13(1):20458. doi: 10.1038/s41598-023-47510-0. Sci Rep. 2023. PMID: 37993560 Free PMC article.
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
van Eerden RAG, de Boer NL, van Kooten JP, Bakkers C, Dietz MV, Creemers GM, Buijs SM, Bax R, de Man FM, Lurvink RJ, Diepeveen M, Brandt-Kerkhof ARM, van Meerten E, Koolen SLW, de Hingh IHJT, Verhoef C, Mathijssen RHJ, Burger JWA. van Eerden RAG, et al. Among authors: lurvink rj. Br J Surg. 2023 Oct 10;110(11):1502-1510. doi: 10.1093/bjs/znad228. Br J Surg. 2023. PMID: 37467389 Clinical Trial.
The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study.
Bakkers C, van de Vlasakker VCJ, Rovers KPB, Lurvink RJ, Nienhuijs SW, Burger JWA, Creemers GM, Bonhof CS, Mols F, de Hingh IHJT. Bakkers C, et al. Among authors: lurvink rj. Cancers (Basel). 2023 Jan 27;15(3):788. doi: 10.3390/cancers15030788. Cancers (Basel). 2023. PMID: 36765746 Free PMC article.
Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial.
Bakkers C, Rovers KP, Rijken A, Simkens GAAM, Bonhof CS, Nienhuijs SW, Burger JWA, Creemers GJM, Brandt-Kerkhof ARM, Tuynman JB, Aalbers AGJ, Wiezer MJ, de Reuver PR, van Grevenstein WMU, Hemmer PHJ, Punt CJA, Tanis PJ, Mols F, de Hingh IHJT; Dutch Peritoneal Oncology Group and the Dutch Colorectal Cancer Group. Bakkers C, et al. Ann Surg Oncol. 2023 May;30(5):2678-2688. doi: 10.1245/s10434-023-13116-z. Epub 2023 Feb 8. Ann Surg Oncol. 2023. PMID: 36754943 Free PMC article. Clinical Trial.
35 results